CLINICAL_TRIALS
trial_result
· 2021-01-27
Clinical Trial Update: Mylan Insulin Aspart Study [Phase 3]
Summary
Phase 3 clinical trial update for Mylan insulin aspart in Type 1 diabetes; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mylan Inc. | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2021-01-27